USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Diabetes
Subscribe to RSS Feed-
01 Jul 2015 | North America | Market Research
Analysis of the US and European Diabetes Diagnostics Market
Constricting Reimbursement Policies Restrain Market Growth
The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-...
$6,950.00 -
This research service analyzes the market for diabetes in vitro diagnostics within the United States. This service covers market trends, technology trends, competitive structure, revenue forecasts, market drivers and restraints. The key challenges and strategies are also covered.
$4,950.00 -
This research service covers the pharmaceutical industry development pipeline for diabetes mellitus in the United States, with 2005 as the base year. Included are both the products projected to enter the market by the end of the forecast coverage period in 2012, as well as products entering the market in 2005 that correspond to the in-depth discuss...
$4,950.00
